HIV
Latest News
Protease inhibitors increase small-for-gestational-age but not other pregnancy risks
Protease inhibitors remain an important option for pregnant women living with HIV if other treatments are unsuitable or unavailable.
News
FDA approves HIV injectable Cabenuva initiation without oral lead-in
Cabenuva injections may be given as few as six times a year to manage HIV.
Feature
More questions than answers when managing HIV and menopause
From the Journals
Antiretroviral therapy associated with less risk of preterm birth
From the Journals
Schizophrenia and HIV: missed opportunities for care
Current guidelines need to reflect the role that patients with HIV and psychiatric comorbidities play in HIV transmission.
From the Journals
MSM have higher CD4 counts at HIV diagnosis than heterosexuals
“We were stunned.”
Feature
Honoring Dr. Paul Farmer: Dr. Serena Koenig shares her memories of working with him
Dr. Farmer and his colleagues at Partners in Health started the HIV Equity Initiative, which was one of the first programs in the world to provide...
Recap
HIV Management: Insights Into ART and Weight Gain
The relationship between antiretroviral therapy and weight gain in people living with HIV, as well as implications of excessive weight gain in HIV...
Conference Coverage
HIV: Dual therapy with twice-yearly injections on the horizon
“Clearly it’s incredibly exciting to have the option for a subcutaneous drug that could be given at home every 6 months.”
Conference Coverage
Full results of anal cancer study point to barriers to care
Infrastructure, algorithms, and workforce training are going be needed to meet the currently unserved people through use of high-resolution...
Conference Coverage
Third transplant patient cured of HIV marks important firsts
“A bone marrow transplant is not a viable large-scale strategy for curing HIV, but it does present a proof of concept that HIV can be cured.”